legal, legislation
August 22, 2018

Louisiana Hepatitis C Cost Proposal

      As drug costs continue to capture national attention and the Trump Administration tries its hand at providing relief, Louisiana has rolled out a proposal that the state believes can help assist with affording the high cost of hepatitis C drugs.  Hepatits C is a blood borne infectious disease caused by the Hepatitis C virus, with no cure or vaccine currently available.  Globally, an estimated 71 million people have chronic hepatitis C infection, and a significant number of those who are chronically infected will develop cirrhosis or liver cancer. (more…)
Read More